We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

immatics Receives €22 Million Final Tranche of Series D Fundraising

News   Jul 17, 2014

 
immatics Receives €22 Million Final Tranche of Series D Fundraising
 
 
 

RELATED ARTICLES

"Exhausted" T Cells Lose the Battle Against Disease

News

A new study has identified the molecular mechanisms behind which T cells will lose the battle against cancer earlier, which could inform treatment.

READ MORE

Personalized Immunotherapy Refined by Mass Spec-Machine Learning Pairing

News

A combination of mass spectrometry and a novel computational tool is more accurately identifying the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

READ MORE

New Drug Combo Could Work Against Broader Array of Cancer Cells

News

Researchers have discovered two drugs that work together to disrupt cancer cells’ ability to survive.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE